Articles and Blogs

On May 1, 2026, the Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 26-09 (“AO 26-09”), which opines on a pediatric dental and orthodontic service provider’s (“Requestor’s”) proposal to offer free orthodontic treatment for one patient per year at each of Requestor’s three practice locations (the “Proposed Arrangement”). How…Read More

Recent Revista data indicated that, over the past decade, the West Coast and Southeast have shown consistently high health care GDP growth, while the Midwest and Northeast (except NY) have shown consistently lower growth. A second post specific to MOB rents showed that certain metros in FL, IN, AL, TN and NC have significantly outperformed…Read More

On April 14, 2026, the Centers for Medicare & Medicaid Services (“CMS”) published the Fiscal Year (“FY”) 2027 Inpatient Prospective Payment System (“IPPS”) Proposed Rule (the “Proposed Rule”), which can be found here. Among other things, the Proposed Rule would make updates to Graduate Medical Education (“GME”) policies for teaching hospitals under the Medicare program….Read More

Indiana Medicaid’s effort to rein in Applied Behavior Analysis (“ABA”) therapy costs has led to a proposed moratorium on provider enrollment. On May 7, 2026, the Indiana Health Coverage Programs (“IHCP”) announced it is seeking approval from the Centers for Medicare and Medicaid Services (“CMS”) to implement the statewide provider enrollment moratorium, beginning June 6,…Read More

On May 13, 2026, as part of its ongoing effort to address home health and hospice fraud, the Trump administration announced a 6-month moratorium on new Home Health and Hospice enrollment, effective immediately. The federal register notice for home health and hospice is set to be published on May 15, 2026. In general, the moratorium…Read More

On April 29, 2026, the U.S. Food and Drug Administration (“FDA” or the “Agency”) issued a Request for Information (“RFI”) seeking stakeholder input on a proposed pilot program evaluating the use of artificial intelligence (“AI”) to optimize early-phase clinical trials. The initiative is intended to assess how AI-enabled technologies “can improve efficiency, speed and quality…Read More

On April 28, 2026, the U.S. Food and Drug Administration (“FDA”) announced additional steps in its ongoing initiative to advance real-time clinical trial approaches, including proof-of-concept studies and a request for information supporting a planned pilot program focused on real-time or near-real-time clinical trial data capture and review (the “Announcement”). FDA Commissioner Marty Makary, M.D.,…Read More

Recently, we have seen a surge in new children’s hospital projects across the country. Our team is currently working on multiple new free-standing children’s hospital projects that will have a significant impact on pediatric care in several states. These projects often include joint ventures between children’s hospitals and academic medical centers. Below is a summary…Read More